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Abstract
Background: Long axis strain (LAS) has been shown to be a fast assessable parameter representing global left
ventricular (LV) longitudinal function in cardiovascular magnetic resonance (CMR). However, the prognostic value of
LAS in cardiomyopathies with reduced left ventricular ejection fraction (LVEF) has not been evaluated yet.
Methods and results: In 146 subjects with non-ischemic dilated cardiomyopathy (NIDCM, LVEF ≤45 %) LAS was
assessed retrospectively from standard non-contrast SSFP cine sequences by measuring the distance between the
epicardial border of the left ventricular apex and the midpoint of a line connecting the origins of the mitral valve
leaflets in end-systole and end-diastole. The final values were calculated according to the strain formula.
The primary endpoint of the study was defined as a combination of cardiac death, heart transplantation or aborted
sudden cardiac death and occurred in 24 subjects during follow-up. Patients with LAS values > −5 % showed a
significant higher rate of cardiac events independent of the presence of late gadolinium enhancement (LGE). The
multivariate Cox regression analysis revealed that LVEDV/BSA (HR: 1.01, p < 0.05), presence of LGE (HR: 2.51, p < 0.05)
and LAS (HR: 1.28, p < 0.05) were independent predictors for cardiac events. In a sequential cox regression analysis
LAS offered significant incremental information (p < 0.05) for the prediction of outcome in addition to LGE and
LVEDV/BSA. Using a dichotomous three point scoring model for risk stratification, including LVEF <35 %, LAS >
−10 % and the presence of LGE, patients with 3 points had a significantly higher risk for cardiac events than those
with 2 or less points.
Conclusion: Assessment of long axis function with LAS offers significant incremental information for the prediction
of cardiac events in NIDCM and improves risk stratification beyond established CMR parameters.
Keywords: Dilated cardiomyopathy, Cardiovascular magnetic resonance, Prognosis, Left ventricular function, Long
axis strain
Background
Non-ischemic dilated cardiomyopathy (NIDCM) is the
second most common aetiology of heart failure and a
leading indication for heart transplantation [1, 2]. Al-
though there has been a significant improvement in
prognosis in NIDCM over the last decades, mortality is
still high and an early diagnosis and risk stratification is
crucial [3]. The main features of NIDCM are left ven-
tricular dilatation and systolic dysfunction, while patients
present with heterogeneous symptoms, ranging from
asymptomatic patients to terminal heart failure [4]. Clas-
sical risk factors, which are associated with a poor prog-
nosis, include age and male gender, NYHA class,
impaired left ventricular ejection fraction (LVEF) and
specific cardiac biomarkers [5–7]. Moreover, presence of
fibroses, which can be seen in about 30 % of the patients
with NIDCM, is associated with poor prognosis [8–10].
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Due to its excellent intrinsic blood-to-tissue contrast
and high reproducibility, cardiovascular magnetic reson-
ance (CMR) is nowadays considered as the non-invasive
gold standard for the evaluation of left ventricular (LV)
function [11]. Additionally, assessment of late gadolin-
ium enhancement (LGE) permits diagnostic classifica-
tion and risk stratification in patients with NIDCM [8,
12–15].
The assessment of myocardial strain provides add-
itional prognostic value in heart failure patients [16–18].
Lately, it has been shown that measurement of cardiac
strain with feature tracking software (FTI) provides in-
cremental prognostic information in NIDCM patients
[19].
Lately, we established long axis strain (LAS) in CMR
as a reliable and fast assessable parameter for LV global
longitudinal function which provides high sensitivity and
specificity in discriminating patients with cardiomyopa-
thies from healthy subjects without the necessity of any
additional offline deformation analysis software tools
and without application of gadolinium contrast agents.
Moreover, LAS analysis shows good inter- and intraob-
server agreement and can be performed much faster
than FTI derived strain analysis [20]. However, until
now there exist no data about the prognostic value of
LAS analysis in cardiomyopathies with reduced LVEF.
The aim of the present study was to evaluate whether
LAS assessed with CMR offers prognostic information
besides standard CMR parameters in patients with
NIDCM.
Methods
Study population
Our study population consisted initially of 210 consecu-
tive patients with NIDCM who were prospectively in-
cluded in our study after referral to the ‘Cardiomyopathy
Center’ at the University Hospital Heidelberg between
May 2005 and November 2009. 64 patients had an LVEF
over 45 % and were therefore excluded. LAS was ana-
lyzed retrospectively in 146 patients. A part of the popu-
lation was previously reported [19]. CMR was performed
as part of our standard institutional protocol for the
evaluation of cardiomyopathies, unless one of the follow-
ing contraindications for CMR was present: cardiac
pacemaker or implantable cardioverter defibrillator
(ICD), other CMR incompatible metallic implants, se-
vere claustrophobia, obesity preventing patient to enter
the scanner bore, pregnancy and lactation. Chronic renal
failure with an estimated GFR <30 ml/min/1.73 m2 was
added as an exclusion criterion for administration of
intravenous CMR contrast agents after July 2007.
The diagnosis of NIDCM was based on the 1995
World Health Organization/International Society and
Federation of Cardiology criteria [21]. Inclusion criteria
for the current retrospective analysis were: impaired sys-
tolic function (LVEF ≤45 %) assessed with CMR and ab-
sence of (i) significant coronary artery disease (defined
as ≥50 % luminal stenosis in one coronary artery) by
coronary angiography, previous coronary revasculariza-
tion or myocardial infarction, (ii) valvular disease, (iii)
hypertensive heart disease and (iv) congenital abnormal-
ities. All patients had congestive heart failure and were
examined in a clinically stable condition (NYHA func-
tional class <III). All patients gave their informed con-
sent and our investigation was carried out after approval
by the local Ethics Committee of the University of Hei-
delberg and in accordance with the Declaration of
Helsinki.
Follow-up data and definition of study endpoints
Cardiac death, heart transplantation and sudden cardiac
death aborted by appropriate ICD discharge due to ven-
tricular tachycardia or fibrillation were defined as hard
cardiac events building the primary endpoint of our
study. Cardiac events together with the occurrence of
hospitalization due to congestive heart failure were used
as a secondary endpoint. In case of patients undergoing
heart transplantation, the follow-up data was censored
at the time of transplantation. In case of several simul-
taneous cardiac events per patient, the worst event was
selected (cardiac death > transplantation > aborted SCD
due to appropriate ICD shock > hospitalization due to
heart failure). Otherwise, only the first event for each pa-
tient was included in the analysis for composite end-
points. Personnel unaware of the CMR results contacted
each subject or an immediate family member for acqui-
sition of the follow-up data.
CMR acquisition and analysis
Standard CMR was performed on a 1.5T clinical scanner
(Achieva®, Philips Healthcare, Best, The Netherlands)
equipped with a cardiac phased array receiver coil. Cine
images were obtained using a breath-hold segmented-k-
space balanced fast-field echo sequence (SSFP) employ-
ing retrospective ECG gating in long axis planes (2, 4
and 3 chamber views) as well as in contiguous short axis
slices covering the whole ventricles from the annulus of
the atrioventricular valves to the apex, with 35 phases
per cardiac cycle. All analyses were performed on a com-
mercially available workstation (Viewforum®, Philips
Healthcare). Results for ventricular volumes, ejection
fraction and LV myocardial mass were derived from
short axis slices. The presence of late gadolinium en-
hancement was evaluated by two independent observers
experienced in CMR, who were blinded to clinical data
and outcome. To exclude artefact, LGE was deemed
present only if visible in two orthogonal views. Left
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ventricular global function index (LVGFI) was assessed
as described previously [22].
Assessment of LAS
Values for LAS were assessed in 2 and 4 chamber views
by measuring displacement of the mitral annulus. The
distance between the epicardial border of the LV apex
and the middle of a line connecting the origins of the
mitral valve leaflets was measured in both end-systole
and end-diastole. The value in percentage for LAS was
finally determined according to the strain formula:
LAS ¼ lengthend−systole−lengthend−diastole
lengthend−diastole
 100
Mean values in 2- and 4-chamber views were calcu-
lated. All values were assessed with the IntelliSpace Por-
tal (ISP) workspace (Version 6, Philips Healthcare, Best,
the Netherlands). An example of the technique in a pa-
tient with a severe NIDCM is shown in Fig. 1. The tech-
nique has been described and validated in detail
previously [20].
Intra- and interobserver variability
For calculation of intra- and interobserver variability 20 sin-
gle measurements were used. To examine intraobserver
variability, a sample of 20 randomly selected CMR scans
for the measurement of LAS were randomly selected for
masked review by the same investigator. The same studies
were analysed by a co-investigator, who was blinded to the
clinical information and the results of the first investigation,
in order to measure interobserver variability.
Statistics
Statistical analysis was carried out using the software so-
lution MedCalc (Version 13.1.2.0, MedCalc Software,
Ostend, Belgium). Continuous variables are expressed as
mean ± standard deviation. For the comparison of means
between groups, two-tailed Student’s t-test was used.
Proportions of categorical were compared using Chi-
squared test. Survival curves were plotted using the
Kaplan-Meier method and p-values were determined by
log-rank testing. The calculation of optimal cut-off
values was carried out by receiver operating characteris-
tics (ROC) analysis. Cox proportional hazards models
were used for uni- and multivariate analysis, which
yielded hazard ratios (HR) and the corresponding 95 %
confidence intervals (CI). P-values <0.05 were regarded
as significantly different. After successful testing for nor-
mal distribution with Shapiro-Wilk test, correlation co-
efficients were expressed as Pearson’s r.
Results
Clinical characteristics
One-hundred-forty-six patients were included for data
collection. During a follow-up period of 4.3 ± 2.0 years,
24 hard cardiac events occurred (cardiac death, heart
transplantation or aborted sudden cardiac death due to
appropriate ICD shock delivery), declared as primary
endpoint. Further 10 patients were admitted to the hos-
pital due to severe heart failure symptoms during the
follow-up period (composite secondary endpoint, n =
34). The baseline characteristics of the study population
are shown in Table 1. The mean values for all CMR pa-
rameters in patients with cardiac events including LAS
were significantly different from those in patients with-
out cardiac events (Table 2). The mean values for LAS
were −5.1 ± 2.6 % in patients with endpoint and −8.5 ±
3.2 % in patients without endpoint (p < 0.0001).
Intra- and interobserver variability
Intra- and interobserver variability for single measure-
ments of LAS were low with 5.1 ± 3.8 % and 5.3 ±
3.9 %, respectively.
Fig. 1 Representative image illustrating the technique for assessment LAS in a patient with severe NIDCM in end-diastole (a) and end-systole (b)
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Survival analysis
ROC analysis yielded a LAS cut-off value of −5.0 % for the
primary endpoint (AUC of 0.81 sensitivity of 62.5 %, speci-
ficity of 88.5 %). Kaplan-Meier curves for the primary and
secondary endpoint concerning the whole study cohort
are shown in Fig. 2. Patients with LAS of −5.0 % or worse
showed a significantly higher rate of cardiac events. For
both, the primary and secondary endpoint, a LAS cut-off
value of −5.0 % was highly prognostic for the prediction of
cardiac events in patients with or without LGE (Fig. 3).
Uni- and multivariate analysis and comparison to LVEF
and LGE
Table 3 shows the results of univariate analysis regarding
clinical and CMR data. According to the analysis, age,
LVEF, left ventricular end-diastolic volume (LVEDV)/
body surface area (BSA), the presence of LGE, LVGFI
and LAS were univariate predictors of cardiac events. In
a stepwise multivariate Cox regression analysis including
the LVEF, the presence of LGE, LVGFI, LVEDV/BSA and
LAS, LAS (HR: 1.28, p = 0.006), LVEDV/BSA (HR: 1.01,
Table 1 Baseline characteristics of the study population
Parameter All patients (n = 146) Patients without endpoint (n = 112) Patients with endpoint (n = 34) P-value
Clinical data
Age (years) 53 ± 14 52 ± 14 57 ± 15 NS
Male gender, n (%) 116 (80) 90 (80) 26 (76) NS
Arterial hypertension, n (%) 64 (44) 48 (43) 16 (47) NS
Hyperlipidaemia, n (%) 27 (18) 21 (19) 6 (18) NS
Smoking, n (%) 50 (34) 41 (37) 9 (36) NS
Diabetes mellitus, n (%) 20 (14) 16 (14) 4 (12) NS
Familiar cardiomyopathy, n (%) 14 (10) 13 (12) 1 (3) NS
Body mass index (kg/m2) 25.7 ± 3.9 25.7 ± 3.9 25.5 ± 3.7 NS
NYHA Class
I, n (%) 18 (12) 13 (12) 5 (15) NS
II, n (%) 72 (49) 60 (54) 12 (35) NS
III, n (%) 56 (38) 39 (35) 17 (50) NS
Laboratory data
Serum creatinine (mg/dL) 1.12 ± 1.00 1.13 ± 1.13 1.07 ± 0.35 NS
Cardiac medications
β-blockers, n (%) 141 (97) 108 (96) 33 (97) NS
ACE-Inhibitors/AT II blockers, n (%) 143 (98) 109 (97) 34 (100) NS
Spironolactone, n (%) 79 (54) 61 (54) 18 (53) NS
Diuretics, n (%) 91 (62) 67 (60) 24 (71) NS
Digoxin, n (%) 31 (21) 18 (16) 13 (38) <0.05
Coumadine, n (%) 61 (42) 44 (39) 17 (50) NS
Table 2 CMR parameter
Parameter All patients (n = 146) Patients without endpoint (n = 112) Patients with endpoint (n = 34) P-value
LVEDV (mL) 291 ± 102 276 ± 88 341 ± 127 0.05
LVEDV/BSA (mL/m2) 148 ± 50 140 ± 41 175 ± 66 <0.0001
LVESV (mL) 214 ± 104 195 ± 86 275 ± 132 <0.0001
LVESV/BSA (mL/m2) 108 ± 52 98 ± 41 143 ± 69 <0.0001
LVEF (%) 29.3 ± 11.0 31.5 ± 10.1 22.0 ± 10.9 <0.0001
LVGFI (%) 20.3 ± 8.0 22.0 ± 7.5 14.8 ± 7.2 <0.0001
Cardiac output (L/min) 5.5 ± 1.6 5.6 ± 1.6 5.1 ± 1.7 NS
Cardiac output index (L/min*m2) 2.8 ± 0.8 2.9 ± 0.7 2.6 ± 0.8 <0.05
LGE present, n (%) 64 (44) 44 (39) 20 (59) <0.05
LAS (%) −7.7 ± 3.4 −8.5 ± 3.2 −5.1 ± 2.6 <0.0001
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Fig. 2 Kaplan-Meier curves including all patients (n = 146) for the primary (a) and secondary (b) endpoint (LAS cut-off value: −5.0 %)
Fig. 3 Kaplan-Meier curves for the primary (a+c) and secondary (b+d) endpoint including patients with and without LGE (LAS cut-off
value: −5.0 %)
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p = 0.044) and the presence of LGE (HR: 2.51, p = 0.046)
remained the only significant parameters regarding the
primary endpoint (Table 4). LVGFI and LVEF were no
longer significant variables in this model. For the sec-
ondary endpoint, LAS remained the only independent
predictor for adverse events (HR: 1.26, p = 0.009), sur-
passing LVEDV/BSA and LGE. To further test the pre-
dictive power of LAS we performed a sequential Cox
regression analysis regarding the primary endpoint.
Hereby, the addition of LAS to a model including LGE
and the LVEDV/BSA led to a significant increase in the
predictive power of this model (Fig. 4 and Table 5).
Dichotomous prognosis scoring system
For risk stratification in patients with NIDCM exclu-
sively with CMR, we created a three point scoring model
including LVEF, the presence of LGE and LAS using the
following criteria: LVEF <35 %, LGE present and LAS >
−10 %. We used a cut-off value for the LVEF <35 % as
this is also the recommended cut-off value for the need
of a defibrillator in ischemic cardiomyopathies and for
LAS > −10 % as there was no single cardiac event in pa-
tients with LAS values better than −10 % in our patient
collective. The scoring system and the resulting Kaplan-
Meier curves can be found in Fig. 5. We observed that
patients with 3 points had significant higher rates of
hard cardiac events during the follow-up period than
those with 2 or fewer points.
Discussion
LAS has been shown to be a simple and rapidly assess-
able parameter representing global LV longitudinal func-
tion without necessity of post-processing software tools
[20]. In the present study we evaluated for the first time
the prognostic value of LAS in patients with NIDCM.
As a main finding we observed that LAS was signifi-
cantly associated with hard cardiac events in NIDCM
patients with or without appearance of LGE. More im-
portantly, a dichotomous scoring system including
standard CMR parameters and LAS may help to identify
high-risk patients with NIDCM. Patients with 3 points
(LVEF <35 %, presence of LGE and LAS > −10 %) had a
probability for cardiac events over 50 %, while in pa-
tients with 0 points no event occurred during the
follow-up period.
In patients with suspected heart failure an early diag-
nosis, a precise risk stratification and the detection of
adverse cardiac remodelling is essential for early thera-
peutic intervention and reduction of mortality [23]. Due
to its excellent intrinsic blood-to-tissue contrast and
high reproducibility, CMR has emerged as an accurate
method for the evaluation of left ventricular function,
which can be used for cost-effective and accurate diag-
nostic classification of patients with heart failure [11].
The complex myocardial deformation behaviour can
be characterized by means of longitudinal, circumferen-
tial and torsional parameters. The measurement of LVEF
alone gives an incomplete representation of the cardiac
function [24]. Despite several studies which emphasize
the incremental value of strain imaging for the detection
of ischemic myocardium and for the risk stratification of
patients with ischemic heart disease and cardiomyopa-
thies [16, 17, 19, 25], important clinical decision mak-
ings e.g. regarding implantation an ICD, initiate cardiac
resynchronization therapy or adjust medical treatment
Table 3 Univariate analysis of all patients (n = 146) for primary and secondary endpoint
Variable Primary endpoint Secondary endpoint
HR 95%CI p-value HR 95%CI p-value
Gender 0.91 0.34–2.43 0.85 0.77 0.35–1.70 0.52
Age (yrs) 1.02 0.99–1.05 0.15 1.03 1.00–1.05 0.04
NYHA class 1.13 0.60–2.11 0.70 1.32 0.78–2.26 0.31
LVEF (%) 0.90 0.86–0.94 <0.0001 0.92 0.89–0.95 <0.0001
LVEDV/BSA (ml/m2) 1.02 1.01–1.02 <0.0001 1.01 1.01–1.02 <0.0001
LGE present 3.43 1.42–8.27 0.006 2.00 1.01–3.95 0.048
LVGFI (%) 0.86 0.81–0.91 <0.0001 0.89 0.85–0.93 <0.0001
LAS (%) 1.46 1.25–1.71 <0.0001 1.41 1.23–1.60 <0.0001
Univariate analysis revealed that LVEF, LVEDV/BSA, LGE present, LVGFI and LAS were significant paramters regarding the primary endpoint, while age, LVEF,
LVEDV/BSA, LGE present, LVGFI and LAS were significantly associated with the secondary endpoint (significant p-values in bold letters)
Table 4 Multivariate proportional-hazard model including LAS,
LVGFI, LVEDV/BSA, LVEF and LGE (all patients) for primary and
secondary endpoint
Variable Primary endpoint Secondary endpoint
HR 95%CI p-value HR 95%CI p-value
LVEDV/BSA (ml/m2) 1.01 1.00–1.02 0.044 1.00 0.99–1.01 0.84
LGE present 2.51 1.02–6.19 0.046 1.64 0.82–3.29 0.16
LAS (%) 1.28 1.07–1.52 0.006 1.26 1.06–1.50 0.009
In the multivariate analysis LVEDV/BSA, LGE present and LAS were significantly
associated with the primary endpoint, while LAS was the only significant
parameter regarding the secondary endpoint (significant p-values in
bold letters)
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are often based on cardiac function as assessed by the
LVEF [26–28].
Echocardiographic studies showed that measurement
of LVEF has high observer variability and poor agree-
ment with other methods [29–31]. Particularly quantifi-
cation of longitudinal strain may therefore be a better
measure of contractile cardiac function than calculating
the LVEF [32]. Carlsson et al. analyzed longitudinal
atrio-ventricular plane displacement with CMR in nor-
mal subjects, professional athletes and patients with di-
lated cardiomyopathy and reduced LVEF (<30 %). They
could show that the percentage of the stroke volume
generated by longitudinal function was similar in all
groups at about 60 % even though stroke volume was
higher in athletes and lower in patients with cardiomy-
opathy [33].
Several studies support our hypothesis that longitu-
dinal function assessment is a better indicator for prog-
nosis in various cardiovascular diseases [34–37]. In a
prospective study of Sveälv et al. longitudinal function
assessed with echocardiography remained an independ-
ent prognostic variable for survival in NIDCM patients,
emphasising the importance of the basal segments of the
ventricles for ventricular function [38]. Other groups re-
ported similar data on heart failure patients (ischaemic
and non-ischaemic cardiomyopathy) conforming that
the estimation of longitudinal function by strain imaging
is a useful surrogate of all-cause mortality [39, 40]. How-
ever, most of these data are based on echocardiographic
assessment of cardiac deformation.
In a recently published CMR study Gjesdal et al. ana-
lyzed LAS and its association with outcome in the
Multi-Ethnic Study of Atherosclerosis (MESA). In this
study, LAS was measured in a similar approach as previ-
ously described by us and was found to be a significant
predictor for cardiac events in a multi-ethnic population
[41]. Lately, we could show that FTI derived longitudinal
strain is an independent predictor of survival in patients
with NIDCM and offers incremental information for risk
stratification beyond clinical parameters, biomarker, and
standard CMR [19]. Motoki et al. observed in patients
with systolic heart failure that global longitudinal strain
assessed with echocardiography was the most robust
strain parameter for risk stratification of patients with
non-ischemic heart failure and provides incremental
prognostic value to the LVEF [16]. A meta-analysis of
Kalam et al. confirmed the strong prognostic value of
global longitudinal strain (GLS) determined by echocar-
diography in different cardiovascular diseases and con-
cluded that GLS may even be superior in predicting
major cardiovascular events than the LVEF [42]. This is
in line with our findings as CMR-derived LAS is signifi-
cantly associated with outcome in NIDCM patients.
Compared to the studies mentioned above we evaluated
a parameter which has several advantages particularly for
usage in clinical routine. Major drawbacks of FTI strain
analysis are the need of a specific post-processing software
tool and an elaborate manual marking of the myocardial
borders. By contrast, even in clinical routine LAS can be
measured rapidly based on standard SSFP sequences. Not
only being a readily available parameter, our study could
show that LAS has significant prognostic value in patients
with NIDCM. LAS values > −5.0 % were significantly asso-
ciated with a higher rate of cardiac events irrespectively of
the presence of LGE. This is in concordance with our previ-
ous study on FTI where we could show that longitudinal
strain surpasses LGE in predicting outcome [19]. LAS may
therefore be a safe and cheap alternative to LGE imaging
for risk stratification. Interestingly, in our multivariate ana-
lysis LVEDV/BSA, LGE and LAS were significantly
associated with outcome, while LVEF and LVGFI were no
longer significant variables. On the one hand this may be
due to the fact that LVEF and LVGFI have a high
Fig. 4 Incremental predictive value of LAS regarding the primary
endpoint. In this multivariate model we started with entering the
LVEDV/BAS, followed by adding LGE and LAS. LAS offered gradual
prognostic information to the model (Table 5)
Table 5 Comparison of multivariate Cox-regression models including LGE, LVEDV/BSA and LAS
Comparison of multivariate Cox-regression models; n = 146
Model 1 Model 2 Chi2 difference p
LVEDV/BSA LVEDV/BSA (ml/m2) + LGE present 4.26 <0.05
LVEDV/BSA (ml/m2) + LGE present LVEDV/BSA (ml/m2) + LGE present + LAS (%) 9.33 <0.005
Cox regression analysis revealed a significant increase in the predictive power when adding LAS to a model including LGE and LVEDV/BSA (significant p-values in
bold letters)
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correlation (r = 0.97), on the other hand the patients in our
collective have low LVEF values (29.3 ± 11.0 %), which may
also explain why LVEF is not as strong as in other studies.
Regarding LAS, we observed no single cardiac event in
patients with LAS values better than −10 %. Based on
this information we created a scoring system for risk
stratification based on LAS and well-established, stand-
ard CMR parameters. We decided to use LVEF and not
LVEDV/BSA for our risk stratification model because
LVEF is still the most established parameter for risk
stratification in patients with NIDCM and in a multivari-
ate model including LVEF, LAS and LGE significantly as-
sociated with the endpoint (data not shown). We believe
that for clinical routine LVEF may be better applicable
than LVEDV/BSA.
Hereby, we observed that detection of any LGE, LVEF
below 35 % and LAS > −10 %, while each feature
counted as one point in our scoring system, is highly as-
sociated with cardiac events. In patients without these
risk features (score = 0) no events were observed during
the follow-up period. Although, several studies suggest
that longitudinal function outperforms the LVEF in pre-
dicting survival in cardiomyopathies [42], we here
propose a combined risk index for improved risk stratifi-
cation consisting of LVEF, LGE and LAS.
Limitations
LAS was analyzed retrospectively. LAS does exclusively
represent LV longitudinal strain and does not provide
information about strain rate, intra-myocardial strain or
circumferential and radial strain, which may better re-
flect cardiac function in certain circumstances. Apart
from LAS, no further strain measurements were per-
formed. Extracellular volume could not be analyzed, as
T1 mapping was not available in this study.
Moreover, LAS was exclusively evaluated in NIDCM
patients with EF below 45 %. The applicability of LAS
on patients with mild form of NIDCM has not been
evaluated and has to be tested in further studies.
Conclusion
LAS is a rapidly determinable parameter which can be
assessed easily from routinely acquired, contrast-agent
free cine SSFP sequences. A reduced LAS is significantly
associated with the occurrence of cardiac events. Ac-
cordingly, LAS is of high prognostic value in patients
with NIDCM besides LGE and LVEDV/BSA. The scor-
ing model presented in this work, which combines LVEF
and LGE - the most established CMR parameters- and
LAS, may help to improve risk stratification in NIDCM.
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